Invention Grant
- Patent Title: Compounds for enzyme inhibition
-
Application No.: US13328909Application Date: 2011-12-16
-
Publication No.: US08357683B2Publication Date: 2013-01-22
- Inventor: Kevin D. Shenk , Francesco Parlati , Han-jie Zhou , Catherine Sylvain , Mark S. Smyth , Mark K. Bennett , Guy J. Laidig
- Applicant: Kevin D. Shenk , Francesco Parlati , Han-jie Zhou , Catherine Sylvain , Mark S. Smyth , Mark K. Bennett , Guy J. Laidig
- Applicant Address: US CA South San Francisco
- Assignee: Onyx Therapeutics, Inc.
- Current Assignee: Onyx Therapeutics, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Fish & Richardson P.C.
- Main IPC: A61K31/5377
- IPC: A61K31/5377 ; A61K31/427 ; A61K31/404 ; A61K31/336 ; C07D413/12 ; C07D417/12 ; C07D405/12 ; C07D303/38
Abstract:
One aspect of the invention relates to inhibitors that preferentially inhibit immunoproteasome activity over constitutive proteasome activity. In certain embodiments, the invention relates to the treatment of immune related diseases, comprising administering a compound of the invention. In certain embodiments, the invention relates to the treatment of cancer, comprising administering a compound of the invention.
Public/Granted literature
- US20120088762A1 COMPOUNDS FOR ENZYME INHIBITION Public/Granted day:2012-04-12
Information query
IPC分类:
